Implications and Application of Probiotics in the NICU
Description
Probiotics use in neonates continues to be a topic of interest. While an increasing number of neonatal intensive care units (NICUs) in the US are beginning to use probiotics, many NICUs still don’t. Barriers to the use of probiotics include safety implementation concerns, standardization of formulation, dosage, and duration. Further research must be done to address the benefits and barriers. This panel of experts discusses the historical background, benefits, current clinical evidence, and barriers to the use of probiotics in neonates.
Learning Objectives:
- Describe the role of probiotics in the NICU
- Assess the scientific evidence used to support probiotics in the NICU
- Detail appropriate application of probiotics to clinical practice in neonates
Performance Indicators:
- 8.2.3 Analyzes new information and how it impacts medical nutrition therapy.
- 10.3.6 Develops nutrition prescriptions to communicate clients’/patients’ customized diet and nutrition needs.
- 10.4.4 Considers client/patient factors, nutritional impacts, indications, side effects, contraindications, benefits, risks, alternatives and foundational sciences when prescribing, recommending or administering nutrition-related drug therapy.
-
Arpitha Chiruvolu, MD, FAAP
Neonatologist, Medical Director of NICU, Clinical Associate Professor
Baylor Scott & White University Medical Center at Dallas, Texas; , Texas A&M College of Medicine; Baylor Scott & White Medical Center – McKinney, Texas
-
Heather Hendrikson, RDN, CSP, LD
Clinical Dietitian- NICU and Women’s Services
Baylor Scott & White Health, University Medical Center Dallas, Texas